Associations between personality disorders and cannabis use and cannabis use disorder: a population-based twin study

被引:26
|
作者
Gillespie, Nathan A. [1 ]
Aggen, Steven H. [1 ]
Neale, Michael C. [1 ,2 ]
Knudsen, Gun Peggy [3 ]
Krueger, Robert F. [4 ]
South, Susan C. [5 ]
Czajkowski, Nikolai [3 ,6 ]
Nesvag, Ragnar [3 ,7 ]
Ystrom, Eivind [3 ,8 ,9 ]
Kendler, Kenneth S. [1 ,2 ]
Reichborn-Kjennerud, Ted [3 ,10 ]
机构
[1] Virginia Commonwealth Univ, Dept Psychiat, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Human & Mol Genet, Richmond, VA 23298 USA
[3] Norwegian Inst Publ Hlth, Dept Mental Disorders, Oslo, Norway
[4] Univ Minnesota, Dept Psychol, Minneapolis, MN USA
[5] Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA
[6] Univ Oslo, Dept Psychol, Oslo, Norway
[7] Diakonhjemmet Hosp, Dept Psychiat Res, Oslo, Norway
[8] Univ Oslo, Sect Hlth Dev & Personal Psychol, Dept Psychol, Oslo, Norway
[9] Univ Oslo, Sch Pharm, PharmacoEpidemiol & Drug Safety Res Grp, Oslo, Norway
[10] Univ Oslo, Inst Clin Med, Oslo, Norway
基金
美国国家卫生研究院;
关键词
Cannabis use; cannabis use disorder; environment; genes; personality disorder traits; twin; NATIONAL EPIDEMIOLOGIC SURVEY; SUBSTANCE-USE DISORDERS; ENVIRONMENTAL RISK-FACTORS; PUBLIC-HEALTH TWIN; DSM-IV CRITERIA; DIMENSIONAL REPRESENTATIONS; PSYCHIATRIC-DISORDERS; NORWEGIAN-INSTITUTE; DANISH ADOPTION; MIXTURE-MODELS;
D O I
10.1111/add.14209
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background and Aims Individual differences in DSM-IV personality disorders (PDs) are associated with increased prevalence of substance use disorders. Our aims were to determine which combination of PDs trait scores best predict cannabis use (CU) and cannabis use disorder (CUD), and to estimate the size and significance of genetic and environmental risks in PD traits shared with CU and CUD. Design Linear mixed-effects models were used to identify PD traits for inclusion in twin analyses to explore the genetic and environmental associations between the traits and cannabis use. Setting Cross-sectional data were obtained from Norwegian adult twins in a face-to-face interview in 1999-2004 as part of a population-based study of mental health. Participants Subjects were 1419 twins (mu(age)=28.2years, range=19-36) from the Norwegian Institute of Public Health Twin Panel with complete PD and cannabis data. Measurements PD traits were assessed using DSM-IV criteria. Life-time CU and CUD were based on DSM-IV abuse and dependence criteria, including withdrawal and craving. Findings After adjusting for age and sex, antisocial [beta=0.23, 95% confidence interval (CI)=0.19-0.28] and borderline PDs (beta=0.20, 95% CI=0.14-0.26) were associated strongly with CU. Antisocial (beta=0.26, 95% CI=0.21-0.31) and borderline PDs (beta=0.12, 95% CI=0.06-0.18) were also linked strongly to CUD. Genetic risks in antisocial and borderline PD traits explained 32-60% of the total variance in CU and CUD. Dependent and avoidant PDs explained 11 and 16% of the total variance in CU and CUD, respectively. Conclusions Individual differences in the liability to cannabis use and cannabis use disorder appear to be linked to genetic risks correlated with antisocial and borderline personality disorder traits.
引用
收藏
页码:1488 / 1498
页数:11
相关论文
共 50 条
  • [41] Daily cannabis use, cannabis use disorder, and any medical cannabis use among US adults: Associations within racial, ethnic, and sexual minoritized identities in a changing policy context
    Mauro, Pia M.
    Philbin, Morgan M.
    Greene, Emily R.
    Diaz, Jose E.
    Askari, Melanie S.
    Martins, Silvia S.
    PREVENTIVE MEDICINE REPORTS, 2022, 28
  • [42] A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population- a meta-analysis of 31 studies
    Karina Karolina Kedzior
    Lisa Tabata Laeber
    BMC Psychiatry, 14
  • [43] Clinical and functional outcomes of cannabis use among individuals with anxiety disorders: A 3-year population-based longitudinal study
    Feingold, Daniel
    Rehm, Juergen
    Factor, Hagai
    Redler, Avigayil
    Lev-Ran, Shaul
    DEPRESSION AND ANXIETY, 2018, 35 (06) : 490 - 501
  • [44] Development of an anxiety disorder following an emergency department visit due to cannabis use: a population-based cohort study
    Myran, Daniel T.
    Harrison, Lyndsay D.
    Pugliese, Michael
    Tanuseputro, Peter
    Gaudreault, Adrienne
    Fiedorowicz, Jess G.
    Solmi, Marco
    ECLINICALMEDICINE, 2024, 69
  • [45] Major depression and dimensional representations of DSM-IV personality disorders: a population-based twin study
    Reichborn-Kjennerud, T.
    Czajkowski, N.
    Roysamb, E.
    Orstavik, R. E.
    Neale, M. C.
    Torgersen, S.
    Kendler, K. S.
    PSYCHOLOGICAL MEDICINE, 2010, 40 (09) : 1475 - 1484
  • [46] The familial aggregation of cannabis use disorders
    Merikangas, Kathleen R.
    Li, Julan Julia
    Stipelman, Brooke
    Yu, Kelly
    Fucito, Lisa
    Swendsen, Joel
    Zhang, Heping
    ADDICTION, 2009, 104 (04) : 622 - 629
  • [47] Has the Legalisation of Medical and Recreational Cannabis Use in the USA Affected the Prevalence of Cannabis Use and Cannabis Use Disorders?
    Leung J.
    Chiu C.Y.V.
    Stjepanović D.
    Hall W.
    Current Addiction Reports, 2018, 5 (4) : 403 - 417
  • [48] Avatar Intervention for Cannabis Use Disorder in Individuals with Severe Mental Disorders: A Pilot Study
    Giguere, Sabrina
    Potvin, Stephane
    Beaudoin, Melissa
    Dellazizzo, Laura
    Giguere, Charles-Edouard
    Furtos, Alexandra
    Gilbert, Karine
    Phraxayavong, Kingsada
    Dumais, Alexandre
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (05):
  • [49] Neurocognitive moderation of associations between cannabis use and psychoneuroticism
    Huijbregts, Stephan C. J.
    Griffith-Lendering, Merel F. H.
    Vollebergh, Wilma A. M.
    Swaab, Hanna
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2014, 36 (08) : 794 - 805
  • [50] Cannabis Use, Use Motives and Cannabis Use Disorder Among Berlin College Students
    Naegele, Helene
    Betzler, Felix
    Viohl, Leonard
    Koslowski, Michael
    Ernst, Felicitas
    Petzold, Moritz Bruno
    JOURNAL OF DRUG ISSUES, 2022, 52 (04) : 568 - 584